August 02, 2021
A now-defunct diabetic testing equipment supplier last owned by Abbott Laboratories will cough up $160 million to settle claims that it wrongly paid kickbacks and also charged Medicare for unnecessary equipment, according to the federal government.
February 19, 2019
A now-defunct diabetic testing equipment supplier last owned by Abbott Laboratories violated the False Claims Act by charging Medicare for unnecessary equipment and by paying kickbacks, federal prosecutors intervening in a whistleblower case said Tuesday.